Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
And doctors are hailing it as a research-backed breakthrough medication that could make a big difference
Today @Roche announced positive results from our Phase I clinical trial of CT-388, a dual GLP-1/GIP receptor agonist being developed for the treatment of #obesity and type 2 #diabetes
doi: 10.4049/jimmunol.178.7.4641 97 Al-SadiRGuoSYeDMaTY
& Usala, S
Cht liu nha cao cp, bn b, m bo an ton cho ngi s dng
Ted 13 days ago Return policy Shipping Policy Exclusive offer available 4.4 (27.3K) (345) (641) (448) (636) (99) (64) (4.9K) (5K) (3K) (1.2K) (14) (1.6K) 4.8 (1.5K) (131) (65) (43) (366) (68) (42) (101) (23) (28) (56) (59) (32) 4.7 (15.7K) (75) 25% off (90) 31% off (50) 24% off 65% off (107) 15% off (12) (10) (5) (8) 13% off (5.9K) 17% off (353) 14% off (83) (307) 29% off (177) 10% off (364) (269) 7% off (79) (196) (7) 22% off (89) 30% off (37) (465) (363) (193) (197) (144) 20% off (106) 21% off (58) (1) 4.5 (94.5K) 4.4 (9.5K) 4.9 (407.5K) 4.6 (12K) 4.7 (228.3K) 4.7 (189.6K) 4.7 (151.8K) 4.3 (428.8K) 4.7 (174.4K) 4.5 (179.9K)
US$ 23.57
US$ 25.64
US$ 22.91
US$ 20.51
US$ 22.38
US$ 26.69
US$ 21.36
US$ 21.29
US$ 24.64
